| Original language | English (US) |
|---|---|
| Pages (from-to) | 88-89 |
| Number of pages | 2 |
| Journal | Annals of Emergency Medicine |
| Volume | 79 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2022 |
Funding
Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. The study, (?Oral Ondansetron Administration??) to which the letter reply is relevant was a subanalysis of data collected as part of 2 large randomized controlled trials. The subanalysis was not funded. The randomized controlled trials were funded in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the Canadian Institutes of Health Research, and Emergency Medical Services for Children Program of the Maternal and Child Health Bureau, Health Resources and Services Administration.
ASJC Scopus subject areas
- Emergency Medicine